Quinine as a Tracer for Medication Adherence
Patients who don’t take their medications as prescribed often put themselves at risk for problems including misdiagnoses, complications, and death. A study suggests that adding low doses of quinine to patients’ medications could provide an inexpensive, reliable, and safe method of monitoring whether patients are taking their medications as directed.
Slow-Release Amphetamine Medication Benefits Patients With Comorbid Cocaine Addiction and ADHD
Treatment with an extended-release stimulant medication plus cognitive behavioral therapy was associated with reductions in cocaine use and in attention-deficit/hyperactivity disorder symptoms in patients with both disorders.
On-Site Psychiatric Treatment Improves Abstinence in Teens With Co-occurring Disorders
Six months after they began substance abuse treatment, teens who also participated in therapy for their other psychiatric problems were more likely to demonstrate abstinence than peers who did not receive such services. The study group comprised 419 adolescents seeking treatment for substance abuse at a managed care system in California. Among a subgroup of the adolescents receiving help for both substance abuse and behavioral problems, those receiving colocated services were more likely to be abstinent than those receiving services at separate locations. Source Sterling S., Weisner C
Long-Term Follow-Up of Medication-Assisted Treatment for Addiction to Pain Relievers Yields “Cause for Optimism”
In the first long-term follow-up of patients treated with buprenorphine/naloxone for addiction to opioid pain relievers, half reported that they were abstinent from the drugs 18 months after starting the therapy.